Onshore manufacturing agreement for COVID-19 vaccines

Australia has secured onshore manufacturing agreements for two COVID-19 vaccines should trials prove successful.

A $1.7 billion supply and production agreement is between the Australian Government and:

  • Oxford University and AstraZeneca
  • University of Queensland and CSL

It will provide 84.8 million doses to the Australian population and be almost entirely made in Melbourne, with early access to 3.8 million doses in January and February 2021.

If both vaccines prove safe and effective and meet all the necessary regulatory requirements, they will be available free to every Australian in 2021.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.